We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Kelly Tyler

Kelly H. Tyler MD, FACOG, FAAD

Assistant Professor, Division of Dermatology, Department of Internal Medicine, Department of Obstetrics and Gynecology, Ohio State University Wexner Medical Center, Columbus, Ohio

Kelly Tyler, MD is a Board-Certified Dermatologist and Board-Certified Obstetrician/Gynecologist at the Ohio State University Wexner Medical Center specializing in Medical Dermatology with a focus on both vulvar disease and skin disease in pregnancy. She is also the Director of the Allergic Contact Dermatitis Program and serves as the Assistant Residency Program Director. Dr. Tyler is the editor of the upcoming textbook “Cutaneous Disorders of Pregnancy” and is the Principal Investigator on multiple clinical research trials. She has lectured on both Pregnancy and Medication Safety and Vulvar Dermatoses at the AAD national meeting and has been active as a member of several national committees through the AAD, WDS, and ASDS.  

Disclosures

Dr. Tyler is Principal Investigator for Janssen, Celgene, and Lilly.